
School Daze: Omicron’s Spread Muddles In-Person Learning Debate
Keeping youngsters in school has become a major goal of public health and education authorities. But the current COVID-19 surge might make that harder to do.
Whether children will be returning to schools today after the holiday break depends a lot on where they happen to be living. Today should be the first day back for millions of school children, but about 2100 school districts will be closed or conducting classes remotely, the school 
Esther Choo, MD, an emergency physician and professor at the Oregon Health & Science University, 
In part because of staffing shortages, the Centers for Disease Control and Prevention (CDC) recently 
Linda Spauldling, RN-BC, CIC, CHEC, CHOP, a member of Infection Control Today®’s Editorial Advisory Board (EAB), recently wrote in a a 
Burbio notes that school districts in the Midwest, Northeast, and Sun Belt had been reopening during the autumn, driving the number of districts that continued to teach the children remotely down to 37%. But because of a spike in the Delta variant, that reopening slowed even before South Africa announced the discovery of the Omicron variant on November 24, and the first US case of Omicron had been discovered on 
“As COVID rates rose around the country, we noted in our 
Keeping youngsters in school has become a major goal of public health authorities. On December 17, the CDC unveiled a 
“We now have experience vaccinating children under the age of 17 and over 5 million of whom are under the age of 11,” Walensky said. “Looking specifically at vaccine safety data of over 50,000 children 5 to 11 years old, we found no evidence of serious safety concerns. The most common reported side effects include pain at the injection site, fever, tiredness and headaches and muscle aches, which we know are normal and are signs that the body is building immunity to the virus.”
Those sentiments were echoed this weekend by both education and health care officials.
Education Secretary Miguel Cardona said on 
Anthony Fauci, MD, the director of the National Institute of Allergy and Infectious Diseases and the chief medical advisor to President Joe Biden, told 
The problem with making decisions about what to do in the face of Omicron is a continuation of the problem faced by medical experts and policymakers throughout the pandemic: There’s still a lot we don’t know about what we’re facing.
Kevin Kavangh, MD, another ICT® EAB member, recently 
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.






